[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360281-105":59,"doc-detail-360281-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrative-analysis-of-myeloid-cell-signatures-identifies-a-prognostic-risk-model-and-potential-mechanisms-in-bladder-cancer-research-open-access","Integrative analysis of myeloid cell signatures identifies a prognostic risk model and potential mechanisms in bladder cancer - Research Open Access","","Bladder cancer remains a major public health burden, and the prognostic roles of myeloid cells within the tumor microenvironment are not fully resolved. The study evaluates individual myeloid cell markers using immunohistochemistry and survival analyses, then builds a LASSO-derived myeloid risk model validated in independent cohorts. Multiplex immunofluorescence and RNA sequencing characterize immune landscape changes and signaling pathways across risk groups.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-analysis-of-myeloid-cell-signatures-identifies-a-prognostic-risk-model-and-potential-mechanisms-in-bladder-cancer-research-open-access/360281/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-analysis-of-myeloid-cell-signatures-identifies-a-prognostic-risk-model-and-potential-mechanisms-in-bladder-cancer-research-open-access/360281.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study on bladder cancer?","Question",{"text":113,"@type":114},"To determine how myeloid cell signatures relate to prognosis and to construct a prognostic risk model with potential mechanistic insights for bladder cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are myeloid prognostic markers and the risk model developed?",{"text":118,"@type":114},"Individual myeloid markers are assessed using immunohistochemistry and survival analyses, and a myeloid-based prognostic model is constructed using LASSO regression and validated across independent cohorts.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune and signaling features characterize tumors in the high-risk group?",{"text":122,"@type":114},"The MRS-high group shows activation of the PI3K–AKT signaling pathway, higher PD-L1/FOXP3/CD11b expression, and reduced CD8+ T-cell infiltration, consistent with an immunosuppressive tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},360281,1790149735,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Wang et al. Biology Direct (2026) 21:78 [https://doi.org/10.1186/s13062-026-00785-5](https://doi.org/10.1186/s13062-026-00785-5)  \nBiology Direct  \nRESEARCH Open Access  \nIntegrative analysis of myeloid cell   \nsignatures identifies a prognostic risk model and potential mechanisms in bladder cancer  \nYuhang Wang1, Siyuan Gong2, Jia Shen2, Guangyuan Liu3* and Minfeng Chen1*  \nAbstract  \nBackground Bladder cancer (BLC) is one of the most common malignancies of the urinary system and represents a major public health burden. Myeloid cells are key components of the tumor microenvironment and play critical roles in tumor progression and therapeutic response; however, their prognostic significance in BLC remains incompletely understood.  \nMethods The prognostic value of individual myeloid cell markers was evaluated using immunohistochemistry and survival analyses. A myeloid-based prognostic model was constructed using least absolute shrinkage and selection operator (LASSO) regression. The model was validated across multiple independent cohorts. Multiplex immunofluorescence staining and RNA sequencing were performed to investigate immune landscape alterations and signaling pathways associated with different risk groups.  \nResults High CD68 expression within tumor regions was associated with favorable prognosis, whereas elevated expression of CD14, CD74, CD163, and S100A12 correlated with poor survival outcomes in BLC patients. A myeloid risk score (MRS) was subsequently established and demonstrated robust prognostic performance across validation cohorts. Transcriptomic analysis revealed significant activation of the PI3K–AKT signaling pathway in the MRS  \nhigh group. Furthermore, MRS-high tumors exhibited increased expression of PD-L1, FOXP3, and CD11b, along with reduced CD8⁺ T-cell infiltration, indicating a highly immunosuppressive tumor microenvironment. Potential therapeutic targets and candidate agents for MRS-high patients were also identified.  \nConclusions We developed a robust myeloid cell–based prognostic model that effectively stratifies BLC patients by risk and reveals distinct immunosuppressive mechanisms in high-risk tumors. This model may facilitate personalized prognostic assessment and guide precision therapeutic strategies for patients with bladder cancer.  \nKeywords Bladder cancer, Myeloid cells, Prognosis, Tumor microenvironment  \n*Correspondence:  \nGuangyuan Liu [liuguangyuan80@163.com](liuguangyuan80@163.com)[ ](liuguangyuan80@163.com)Minfeng Chen[chenminfeng1999@csu.edu.cn](chenminfeng1999@csu.edu.cn)  \n1Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China  \n2Key Laboratory of Molecular Radiation Oncology, Xiangya Hospital, Central South University, Xiangya Street, Hunan ProvinceChangsha, PR China  \n3Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, PR China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitt","cbCaipggxgeNpfoV","https://ap.wps.com/l/cbCaipggxgeNpfoV","pdf",6500132,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Bladder cancer burden and current treatment limits\n## Tumor microenvironment and myeloid cell roles","[{\"question\":\"What is the main goal of the study on bladder cancer?\",\"answer\":\"To determine how myeloid cell signatures relate to prognosis and to construct a prognostic risk model with potential mechanistic insights for bladder cancer.\"},{\"question\":\"How are myeloid prognostic markers and the risk model developed?\",\"answer\":\"Individual myeloid markers are assessed using immunohistochemistry and survival analyses, and a myeloid-based prognostic model is constructed using LASSO regression and validated across independent cohorts.\"},{\"question\":\"What immune and signaling features characterize tumors in the high-risk group?\",\"answer\":\"The MRS-high group shows activation of the PI3K–AKT signaling pathway, higher PD-L1/FOXP3/CD11b expression, and reduced CD8+ T-cell infiltration, consistent with an immunosuppressive tumor microenvironment.\"}]","Integrative analysis of myeloid cell signatures identifies a prognostic risk model and potential mechanisms in bladder cancer - Research Open Access | PDF",1790139475,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc7d6cba481690d9080e5de295d97cb0.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a936672f6df25f86aa2ce0a4d009acdf.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/178288fa01359368df26f6a37495ccb1.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3bb23cdb039717768c62c9a24cd699e.webp",980,1306]